
    
      The current clinical trial is an investigator-initiated one, and it is conducted under the
      multi-center, single arm, open-label, prospective design. The subject meeting
      inclusion/exclusion criteria will be assigned to treatment group.

      The subjects of treatment group should be initiated hypothermia therapy as soon as possible
      after surgery (less than 6 hours). It can be duration at least 72 hours according to subject
      status. Also process of recovery temperature period will be allowed within 20-40 hours. After
      6 month, 12 month of the onset of symptom, mRS score are measured. This is followed by
      closure of clinical trial.
    
  